Both nations will work together to strengthen their health information systems through coordinated collection, analysis, and sharing of epidemiological data, scientific research findings, and public health intelligence.
C4 Therapeutics will use its proprietary TORPEDO platform to design the degrader payloads, while Roche will oversee antibody selection, conjugation chemistry, preclinical testing, and clinical development
The partnership seeks to unify healthcare data and convert it into actionable insights that healthcare providers, insurance companies, and government agencies can leverage.
The partnership gives Ajman University students access to three major healthcare facilities: Sheikh Khalifa General Hospital in Umm Al Quwain, Sheikh Khalifa Specialty Hospital in Ras Al Khaimah, and Sheikh Khalifa Medical City in Ajman.
SAT founder and Chief Medical Officer Dr Peter Zilla, alongside co-developers Dr Roman Gottardi and Dr Martin Czerny, confirmed that the results validate the device’s clinical value.
The partnership directly supports Dubai’s D33 Economic Agenda and aims to establish the emirate as a global leader in HealthTech innovation.
The IMARA–BC initiative targets women aged 40 and above, encouraging them to undergo routine screening so that cancer is detected at stage one or two, when treatment is most effective.
The partnership will provide JOOTRH with dedicated advanced facilities, including project-specific space for an Advanced Pathology Lab within the hospital.
The deal aimed to combine Lensar’s innovative cataract surgery technologies with Alcon’s existing portfolio, potentially creating a dominant force in the femtosecond laser-assisted cataract surgery market.
The meeting represents part of the Egyptian Drug Authority’s ongoing efforts to engage with leading international pharmaceutical companies and promote strategic partnerships that support industry development.